|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stein PD, Beemath A, Meyers FA, Skaf E,
Sanchez J and Olson RE: Incidence of venous thromboembolism in
patients hospitalized with cancer. Am J Med. 119:60–68. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woei-A-Jin FJ, Tesselaar ME, Garcia
Rodriguez P, Romijn FP, Bertina RM and Osanto S: Tissue
factor-bearing microparticles and CA19.9: Two players in pancreatic
cancer-associated thrombosis? Br J Cancer. 115:332–338. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haas SL, Jesnowski R, Steiner M, Hummel F,
Ringel J, Burstein C, Nizze H, Liebe S and Löhr JM: Expression of
tissue factor in pancreatic adenocarcinoma is associated with
activation of coagulation. World J Gastroenterol. 12:4843–4849.
2006.PubMed/NCBI
|
|
6
|
Steffel J, Luscher TF and Tanner FC:
Tissue factor in cardiovascular diseases: Molecular mechanisms and
clinical implications. Circulation. 113:722–731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van den Berg YW, Osanto S, Reitsma PH and
Versteeg HH: The relationship between tissue factor and cancer
progression: Insights from bench and bedside. Blood. 119:924–932.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leppert U and Eisenreich A: The role of
tissue factor isoforms in cancer biology. Int J Cancer.
137:497–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kasthuri RS, Taubman MB and Mackman N:
Role of tissue factor in cancer. J Clin Oncol. 27:4834–4838. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Drake TA, Morrissey JH and Edgington TS:
Selective cellular expression of tissue factor in
human-tissues-implications for disorders of hemostasis and
thrombosis. Am J Pathol. 134:1087–1097. 1989.PubMed/NCBI
|
|
11
|
Vrana JA, Stang MT, Grande JP and Getz MJ:
Expression of tissue factor in tumor stroma correlates with
progression to invasive human breast cancer: Paracrine regulation
by carcinoma cell-derived members of the transforming growth factor
beta family. Cancer Res. 56:5063–5070. 1996.PubMed/NCBI
|
|
12
|
Khorana AA, Ahrendt SA, Ryan CK, Francis
CW, Hruban RH, Hu YC, Hostetter G, Harvey J and Taubman MB: Tissue
factor expression, angiogenesis, and thrombosis in pancreatic
cancer. Clin Cancer Res. 13:2870–2875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsumura Y, Kimura M, Yamamoto T and
Maeda H: Involvement of the kinin-generating cascade in enhanced
vascular permeability in tumor tissue. Jpn J Cancer Res.
79:1327–1334. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernandez PM, Patierno SR and Rickles FR:
Tissue factor and fibrin in tumor angiogenesis. Semin Thromb
Hemost. 30:31–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hisada Y, Yasunaga M, Hanaoka S, Saijou S,
Sugino T, Tsuji A, Saga T, Tsumoto K, Manabe S, Kuroda J, et al:
Discovery of an uncovered region in fibrin clots and its clinical
significance. Sci Rep. 3:26042013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saito Y, Hashimoto Y, Kuroda J, Yasunaga
M, Koga Y, Takahashi A and Matsumura Y: The inhibition of
pancreatic cancer invasion-metastasis cascade in both cellular
signal and blood coagulation cascade of tissue factor by its
neutralisation antibody. Eur J Cancer. 47:2230–2239. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ueda C, Hirohata Y, Kihara Y, Nakamura H,
Abe S, Akahane K, Okamoto K, Itoh H and Otsuki M: Pancreatic cancer
complicated by disseminated intravascular coagulation associated
with production of tissue factor. J Gastroenterol. 36:848–850.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kakkar AK, Lemoine NR, Scully MF, Tebbutt
S and Williamson RC: Tissue factor expression correlates with
histological grade in human pancreatic cancer. Br J Surg.
82:1101–1104. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Callander NS, Varki N and Rao LV:
Immunohistochemical identification of tissue factor in solid
tumors. Cancer. 70:1194–1201. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hobbs JE, Zakarija A, Cundiff DL, Doll JA,
Hymen E, Cornwell M, Crawford SE, Liu N, Signaevsky M and Soff GA:
Alternatively spliced human tissue factor promotes tumor growth and
angiogenesis in a pancreatic cancer tumor model. Thromb Res. 120
(Suppl 2):S13–S21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nitori N, Ino Y, Nakanishi Y, Yamada T,
Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M and Hirohashi
S: Prognostic significance of tissue factor in pancreatic ductal
adenocarcinoma. Clin Cancer Res. 11:2531–2539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Contrino J, Hair G, Kreutzer DL and
Rickles FR: In situ detection of tissue factor in vascular
endothelial cells: Correlation with the malignant phenotype of
human breast disease. Nat Med. 2:209–215. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsumura R, Sato R, Furuya F, Koga Y,
Yamamoto Y, Fujiwara Y, Yasunaga M and Matsumura Y: Feasibility
study of the Fab fragment of a monoclonal antibody against tissue
factor as a diagnostic tool. Int J Oncol. 47:2107–2114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koga Y, Manabe S, Aihara Y, Sato R,
Tsumura R, Iwafuji H, Furuya F, Fuchigami H, Fujiwara Y, Hisada Y,
et al: Antitumor effect of antitissue factor antibody-MMAE
conjugate in human pancreatic tumor xenografts. Int J Cancer.
137:1457–1466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takashima H, Tsuji AB, Saga T, Yasunaga M,
Koga Y, Kuroda JI, Yano S, Kuratsu JI and Matsumura Y: Molecular
imaging using an anti-human tissue factor monoclonal antibody in an
orthotopic glioma xenograft model. Sci Rep. 7:123412017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwamura T, Katsuki T and Ide K:
Establishment and characterization of a human pancreatic cancer
cell line (SUIT-2) producing carcinoembryonic antigen and
carbohydrate antigen 19-9. Jpn J Cancer Res. 78:54–62.
1987.PubMed/NCBI
|
|
28
|
Sogawa C, Tsuji AB, Sudo H, Sugyo A,
Yoshida C, Odaka K, Uehara T, Arano Y, Koizumi M and Saga T:
C-kit-targeted imaging of gastrointestinal stromal tumor using
radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model.
Nucl Med Biol. 37:179–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sudo H, Tsuji AB, Sugyo A, Ogawa Y, Sagara
M and Saga T: ZDHHC8 knockdown enhances radiosensitivity and
suppresses tumor growth in a mesothelioma mouse model. Cancer Sci.
103:203–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sugaya A, Hyodo I, Koga Y, Yamamoto Y,
Takashima H, Sato R, Tsumura R, Furuya F, Yasunaga M, Harada M, et
al: Utility of epirubicin-incorporating micelles tagged with
anti-tissue factor antibody clone with no anticoagulant effect.
Cancer Sci. 107:335–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshida C, Tsuji AB, Sudo H, Sugyo A,
Kikuchi T, Koizumi M, Arano Y and Saga T: Therapeutic efficacy of
c-kit-targeted radioimmunotherapy using 90Y-labeled anti-c-kit
antibodies in a mouse model of small cell lung cancer. PLoS One.
8:e592482013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sugyo A, Tsuji AB, Sudo H, Nagatsu K,
Koizumi M, Ukai Y, Kurosawa G, Zhang MR, Kurosawa Y and Saga T:
Evaluation of 89Zr-labeled human anti-CD147 monoclonal
antibody as a positron emission tomography probe in a mouse model
of pancreatic cancer. PLoS One. 8:e612302013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsumura Y and Maeda H: A new concept for
macromolecular therapeutics in cancer chemotherapy: Mechanism of
tumoritropic accumulation of proteins and the antitumor agent
smancs. Cancer Res. 46:6387–6392. 1986.PubMed/NCBI
|
|
34
|
Hong H, Zhang Y, Nayak TR, Engle JW, Wong
HC, Liu B, Barnhart TE and Cai W: Immuno-PET of tissue factor in
pancreatic cancer. J Nucl Med. 53:1748–1754. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Massoud TF and Gambhir SS: Molecular
imaging in living subjects: Seeing fundamental biological processes
in a new light. Genes Dev. 17:545–580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gnanasegaran G and Ballinger JR: Molecular
imaging agents for SPECT (and SPECT/CT). Eur J Nucl Med Mol
Imaging. 41 (Suppl 1):S26–S35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Breij EC, de Goeij BE, Verploegen S,
Schuurhuis DH, Amirkhosravi A, Francis J, Miller VB, Houtkamp M,
Bleeker WK, Satijn D, et al: An antibody-drug conjugate that
targets tissue factor exhibits potent therapeutic activity against
a broad range of solid tumors. Cancer Res. 74:1214–1226. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang B, Berger M, Masters G, Albone E,
Yang Q, Sheedy J, Kirksey Y, Grimm L, Wang B, Singleton J and
Soltis D: Radiotherapy of human xenograft NSCLC tumors in nude mice
with a 90Y-labeled anti-tissue factor antibody. Cancer
Biother Radiopharm. 20:300–309. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jain M, Gupta S, Kaur S, Ponnusamy MP and
Batra SK: Emerging trends for radioimmunotherapy in solid tumors.
Cancer Biother Radiopharm. 28:639–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aung W, Tsuji AB, Sugyo A, Takashima H,
Yasunaga M, Matsumura Y and Higashi T: Near-infrared
photoimmunotherapy of pancreatic cancer using an indocyanine
green-labeled anti-tissue factor antibody. World J Gastroenterol.
24:5491–5504. 2018. View Article : Google Scholar : PubMed/NCBI
|
